What's new in neurofibromatosis? Proceedings from the 2009 NF conference: New frontiers

Joseph L. Kissil, Jaishri O. Blakeley, Rosalie E. Ferner, Susan M. Huson, Michel Kalamarides, Victor Felix Mautner, Frank McCormick, Helen Morrison, Roger Packer, Vijaya Ramesh, Nancy Ratner, Katherine A Rauen, David A. Stevenson, Kim Hunter-Schaedle, Kathryn North

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The NF Conference is the largest annual gathering of researchers and clinicians focused on neurofibromatosis and has been convened by the Children's Tumor Foundation for over 20 years. The 2009NF Conferencewas held in Portland,Oregon fromJune 13 to June 16, 2009 andco-chaired byKathrynNorthfromtheUniversity of Sydney and The Children's Hospital at Westmead, Sydney, Australia; and Joseph Kissil from the Wistar Institute, Philadelphia. The Conference included 80 platform presentations in 9 sessions over 4 days; over 100 abstracts presented as posters; and threeKeynote presentations. To date, there have been tremendous advances in basic research in the pathogenesis of neurofibromatosis, andmore recently in progress toward identifying effective drug therapies and the commencement of neurofibromatosis clinical trials. The NF Conference attendees have significantly increased (doubling from 140 in 2005 to 280 attending in 2009) with a significant increase in attendance of physicians and clinical researchers. Correspondingly theNFConference scope has expanded to include translational research, clinical trials and clinical management issues while retaining a core of basic research. These themes are reflectedin the highlights from the 2009 NF Conference presented here.

Original languageEnglish (US)
Pages (from-to)269-283
Number of pages15
JournalAmerican Journal of Medical Genetics, Part A
Volume152
Issue number2
DOIs
StatePublished - Feb 2010
Externally publishedYes

Fingerprint

Neurofibromatoses
Research Personnel
Clinical Trials
Posters
Translational Medical Research
Research
Physicians
Drug Therapy
Neoplasms

Keywords

  • Bone dysplasia
  • Learning disabilities
  • Neurofibromatosis type 1
  • Neurofibromatosis type 2
  • NF1
  • NF2
  • Ras/MAPK
  • Schwannomatosis
  • Tumor suppressor

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Kissil, J. L., Blakeley, J. O., Ferner, R. E., Huson, S. M., Kalamarides, M., Mautner, V. F., ... North, K. (2010). What's new in neurofibromatosis? Proceedings from the 2009 NF conference: New frontiers. American Journal of Medical Genetics, Part A, 152(2), 269-283. https://doi.org/10.1002/ajmg.a.33189

What's new in neurofibromatosis? Proceedings from the 2009 NF conference : New frontiers. / Kissil, Joseph L.; Blakeley, Jaishri O.; Ferner, Rosalie E.; Huson, Susan M.; Kalamarides, Michel; Mautner, Victor Felix; McCormick, Frank; Morrison, Helen; Packer, Roger; Ramesh, Vijaya; Ratner, Nancy; Rauen, Katherine A; Stevenson, David A.; Hunter-Schaedle, Kim; North, Kathryn.

In: American Journal of Medical Genetics, Part A, Vol. 152, No. 2, 02.2010, p. 269-283.

Research output: Contribution to journalArticle

Kissil, JL, Blakeley, JO, Ferner, RE, Huson, SM, Kalamarides, M, Mautner, VF, McCormick, F, Morrison, H, Packer, R, Ramesh, V, Ratner, N, Rauen, KA, Stevenson, DA, Hunter-Schaedle, K & North, K 2010, 'What's new in neurofibromatosis? Proceedings from the 2009 NF conference: New frontiers', American Journal of Medical Genetics, Part A, vol. 152, no. 2, pp. 269-283. https://doi.org/10.1002/ajmg.a.33189
Kissil, Joseph L. ; Blakeley, Jaishri O. ; Ferner, Rosalie E. ; Huson, Susan M. ; Kalamarides, Michel ; Mautner, Victor Felix ; McCormick, Frank ; Morrison, Helen ; Packer, Roger ; Ramesh, Vijaya ; Ratner, Nancy ; Rauen, Katherine A ; Stevenson, David A. ; Hunter-Schaedle, Kim ; North, Kathryn. / What's new in neurofibromatosis? Proceedings from the 2009 NF conference : New frontiers. In: American Journal of Medical Genetics, Part A. 2010 ; Vol. 152, No. 2. pp. 269-283.
@article{22af0008923d4ad6929fdb6ee1c76639,
title = "What's new in neurofibromatosis? Proceedings from the 2009 NF conference: New frontiers",
abstract = "The NF Conference is the largest annual gathering of researchers and clinicians focused on neurofibromatosis and has been convened by the Children's Tumor Foundation for over 20 years. The 2009NF Conferencewas held in Portland,Oregon fromJune 13 to June 16, 2009 andco-chaired byKathrynNorthfromtheUniversity of Sydney and The Children's Hospital at Westmead, Sydney, Australia; and Joseph Kissil from the Wistar Institute, Philadelphia. The Conference included 80 platform presentations in 9 sessions over 4 days; over 100 abstracts presented as posters; and threeKeynote presentations. To date, there have been tremendous advances in basic research in the pathogenesis of neurofibromatosis, andmore recently in progress toward identifying effective drug therapies and the commencement of neurofibromatosis clinical trials. The NF Conference attendees have significantly increased (doubling from 140 in 2005 to 280 attending in 2009) with a significant increase in attendance of physicians and clinical researchers. Correspondingly theNFConference scope has expanded to include translational research, clinical trials and clinical management issues while retaining a core of basic research. These themes are reflectedin the highlights from the 2009 NF Conference presented here.",
keywords = "Bone dysplasia, Learning disabilities, Neurofibromatosis type 1, Neurofibromatosis type 2, NF1, NF2, Ras/MAPK, Schwannomatosis, Tumor suppressor",
author = "Kissil, {Joseph L.} and Blakeley, {Jaishri O.} and Ferner, {Rosalie E.} and Huson, {Susan M.} and Michel Kalamarides and Mautner, {Victor Felix} and Frank McCormick and Helen Morrison and Roger Packer and Vijaya Ramesh and Nancy Ratner and Rauen, {Katherine A} and Stevenson, {David A.} and Kim Hunter-Schaedle and Kathryn North",
year = "2010",
month = "2",
doi = "10.1002/ajmg.a.33189",
language = "English (US)",
volume = "152",
pages = "269--283",
journal = "American Journal of Medical Genetics",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - What's new in neurofibromatosis? Proceedings from the 2009 NF conference

T2 - New frontiers

AU - Kissil, Joseph L.

AU - Blakeley, Jaishri O.

AU - Ferner, Rosalie E.

AU - Huson, Susan M.

AU - Kalamarides, Michel

AU - Mautner, Victor Felix

AU - McCormick, Frank

AU - Morrison, Helen

AU - Packer, Roger

AU - Ramesh, Vijaya

AU - Ratner, Nancy

AU - Rauen, Katherine A

AU - Stevenson, David A.

AU - Hunter-Schaedle, Kim

AU - North, Kathryn

PY - 2010/2

Y1 - 2010/2

N2 - The NF Conference is the largest annual gathering of researchers and clinicians focused on neurofibromatosis and has been convened by the Children's Tumor Foundation for over 20 years. The 2009NF Conferencewas held in Portland,Oregon fromJune 13 to June 16, 2009 andco-chaired byKathrynNorthfromtheUniversity of Sydney and The Children's Hospital at Westmead, Sydney, Australia; and Joseph Kissil from the Wistar Institute, Philadelphia. The Conference included 80 platform presentations in 9 sessions over 4 days; over 100 abstracts presented as posters; and threeKeynote presentations. To date, there have been tremendous advances in basic research in the pathogenesis of neurofibromatosis, andmore recently in progress toward identifying effective drug therapies and the commencement of neurofibromatosis clinical trials. The NF Conference attendees have significantly increased (doubling from 140 in 2005 to 280 attending in 2009) with a significant increase in attendance of physicians and clinical researchers. Correspondingly theNFConference scope has expanded to include translational research, clinical trials and clinical management issues while retaining a core of basic research. These themes are reflectedin the highlights from the 2009 NF Conference presented here.

AB - The NF Conference is the largest annual gathering of researchers and clinicians focused on neurofibromatosis and has been convened by the Children's Tumor Foundation for over 20 years. The 2009NF Conferencewas held in Portland,Oregon fromJune 13 to June 16, 2009 andco-chaired byKathrynNorthfromtheUniversity of Sydney and The Children's Hospital at Westmead, Sydney, Australia; and Joseph Kissil from the Wistar Institute, Philadelphia. The Conference included 80 platform presentations in 9 sessions over 4 days; over 100 abstracts presented as posters; and threeKeynote presentations. To date, there have been tremendous advances in basic research in the pathogenesis of neurofibromatosis, andmore recently in progress toward identifying effective drug therapies and the commencement of neurofibromatosis clinical trials. The NF Conference attendees have significantly increased (doubling from 140 in 2005 to 280 attending in 2009) with a significant increase in attendance of physicians and clinical researchers. Correspondingly theNFConference scope has expanded to include translational research, clinical trials and clinical management issues while retaining a core of basic research. These themes are reflectedin the highlights from the 2009 NF Conference presented here.

KW - Bone dysplasia

KW - Learning disabilities

KW - Neurofibromatosis type 1

KW - Neurofibromatosis type 2

KW - NF1

KW - NF2

KW - Ras/MAPK

KW - Schwannomatosis

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=75449091573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75449091573&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.33189

DO - 10.1002/ajmg.a.33189

M3 - Article

C2 - 20082461

AN - SCOPUS:75449091573

VL - 152

SP - 269

EP - 283

JO - American Journal of Medical Genetics

JF - American Journal of Medical Genetics

SN - 1552-4825

IS - 2

ER -